Results 311 to 320 of about 193,589 (341)
Some of the next articles are maybe not open access.
, 2020
High intensity focused ultrasound (HIFU) thrombolysis is a non-pharmacological, non-invasive treatment option for the restoration of blood flow through occluded vessels.
Shifang Guo +6 more
semanticscholar +1 more source
High intensity focused ultrasound (HIFU) thrombolysis is a non-pharmacological, non-invasive treatment option for the restoration of blood flow through occluded vessels.
Shifang Guo +6 more
semanticscholar +1 more source
Fibrinolysis, 1994
It is 47 years since the first therapeutic use of streptokinase, 35 years since the first clinical study of thrombolysis in myocardial infarction,’ 15 years since the European Cooperative study trial2 proved its efficacy, and more or less a decade since GISSI-l3 and ISIS-2.4 An update of this type traditionally has three parts: where have we been ...
openaire +2 more sources
It is 47 years since the first therapeutic use of streptokinase, 35 years since the first clinical study of thrombolysis in myocardial infarction,’ 15 years since the European Cooperative study trial2 proved its efficacy, and more or less a decade since GISSI-l3 and ISIS-2.4 An update of this type traditionally has three parts: where have we been ...
openaire +2 more sources
Neurology, 2011
To examine whether prior statin use affects outcome and intracranial hemorrhage (ICH) rates in stroke patients receiving IV thrombolysis (IVT).In a pooled observational study of 11 IVT databases, we compared outcomes between statin users and nonusers.
Engelter +23 more
openaire +3 more sources
To examine whether prior statin use affects outcome and intracranial hemorrhage (ICH) rates in stroke patients receiving IV thrombolysis (IVT).In a pooled observational study of 11 IVT databases, we compared outcomes between statin users and nonusers.
Engelter +23 more
openaire +3 more sources
The Lancet, 1996
SIR—Since only opinions contrary to thrombolysis seem lately to be heard, we feel it is useful to express a critical point of view, starting from Bignall’s report on the 4th International Symposium on Thrombolytic Therapy in Acute Ischaemic Stroke. As you may know, the Acute Stroke Pooling Project did a meta-analysis of the streptokinase trials, so ...
FIESCHI, Cesare, TONI, Danilo
openaire +4 more sources
SIR—Since only opinions contrary to thrombolysis seem lately to be heard, we feel it is useful to express a critical point of view, starting from Bignall’s report on the 4th International Symposium on Thrombolytic Therapy in Acute Ischaemic Stroke. As you may know, the Acute Stroke Pooling Project did a meta-analysis of the streptokinase trials, so ...
FIESCHI, Cesare, TONI, Danilo
openaire +4 more sources
Current Opinion in Neurology, 2003
Stroke thrombolysis is in the process of moving from academic centers into community-based standard therapy in experienced centers. Recently published data on patient selection, imaging and other technical or organizational advances are reviewed in order to improve the safety and efficacy of stroke thrombolysis and identify areas in which more study is
Markku Kaste, Perttu J. Lindsberg
openaire +4 more sources
Stroke thrombolysis is in the process of moving from academic centers into community-based standard therapy in experienced centers. Recently published data on patient selection, imaging and other technical or organizational advances are reviewed in order to improve the safety and efficacy of stroke thrombolysis and identify areas in which more study is
Markku Kaste, Perttu J. Lindsberg
openaire +4 more sources
Effects of Telestroke on Thrombolysis Times and Outcomes: A Meta-analysis
Prehospital Emergency Care, 2018Objective: Telestroke systems are tools, used to provide an advanced stroke care in regions without sufficient neurologic services. We performed this meta-analysis to assess the effects of telemedicine on treatment times and clinical outcomes of acute ...
Alireza Baratloo +5 more
semanticscholar +1 more source
Thrombolysis for Pulmonary Embolism
New England Journal of Medicine, 1991The primary therapy for acute pulmonary embolism is anticoagulation with heparin and warfarin to prevent additional thromboembolism.
openaire +4 more sources
Australian and New Zealand Journal of Medicine, 1993
Abstract:Since 20% of patients with myocardial infarction (MI) have had a previous infarction, and reinfarction within one year after infarction occurs in 9% of cases, it is important to clarify the role of repeat thrombolysis.After streptokinase (SK) administration, IgG antibodies rise to a peak at two weeks and slowly fall over the next 12 months ...
openaire +2 more sources
Abstract:Since 20% of patients with myocardial infarction (MI) have had a previous infarction, and reinfarction within one year after infarction occurs in 9% of cases, it is important to clarify the role of repeat thrombolysis.After streptokinase (SK) administration, IgG antibodies rise to a peak at two weeks and slowly fall over the next 12 months ...
openaire +2 more sources
Unstable angina and thrombolysis
Chest, 1990Unstable angina occurs in a heterogeneous population of patients. In the subset of patients with recent rest angina, both angiographic and angioscopic studies have suggested that coronary artery thrombus is often present and serves as a predictor of subsequent adverse clinical events, including recurrent angina, myocardial infarction, the need for ...
openaire +3 more sources
Archives of Neurology, 1996
Thrombolytictherapy for stroke signals a breakthrough, through clots and nihilistic attitudes. Although a systematic approach to stroke care as exemplified by stroke units has been shown to improve outcomes, 1 recombinant tissue-type plasminogen activator (rt-PA) is the first drug to make a demonstrable difference to stroke.
openaire +5 more sources
Thrombolytictherapy for stroke signals a breakthrough, through clots and nihilistic attitudes. Although a systematic approach to stroke care as exemplified by stroke units has been shown to improve outcomes, 1 recombinant tissue-type plasminogen activator (rt-PA) is the first drug to make a demonstrable difference to stroke.
openaire +5 more sources